Skip to main content
. Author manuscript; available in PMC: 2017 Oct 17.
Published in final edited form as: Biomaterials. 2016 Jul 26;104:361–371. doi: 10.1016/j.biomaterials.2016.07.029

Table 1.

The ROI analysis of major organs from PET (unit: %ID/g)

Time Point Tissue 64Cu-NOTA-GO-FSHR-mAb 64Cu-NOTA-GO-FSHR-mAb with denature 64Cu-NOTA-GO
0.5 h Liver 16.5 ±4.0 20.4 ±1.2 18.8 ±5.0
Tumor 10.6 ±1.1 2.9 ±0.2 3.8 ±0.4
Blood 7.2 ±2.0 3.6 ±0.2 4.2 ±1.0
Muscle 0.7 ±0.3 0.7 ±0.1 0.6 ±0.1
2 h Liver 17.8± 1.2 19.3 ±1.5 20.8 ±3.0
Tumor 10.6 ±1.0 2.8 ±0.4 3.1 ±0.5
Blood 4.6 ±1.7 2.9 ±0.2 3.6 ±0.8
Muscle 0.6 ±0.2 0.7 ±0.1 0.5 ±0.2
4 h Liver 15.8± 2.5 14.3 ±4.5 19.1 ±2.8
Tumor 11.6± 1.1 2.4 ±0.2 3.3 ±0.7
Blood 4.5 ±0.5 3.6 ±0.8 3.3 ±0.7
Muscle 0.6± 0.3 0.6 ±0.1 0.6 ±0.2
24 h Liver 15.6± 1.9 13.6 ±2.5 17.5 ±2.9
Tumor 9.3 ±0.9 2.5 ±0.2 1.9 ±0.4
Blood 4.7± 1.1 4.2 ±1.0 1.4 ±0.1
Muscle 0.6 ±0.2 0.6 ±0.02 0.6 ±0.1